Search results for: 'pi3 kinase p110'
-
BA4961 CC-90005Summary: CC-90005 is a potent, selective and orally active protein kinase C-theta inhibitor. - BA5769 BDP9066Summary: BDP9066 is a selective and potent inhibitor of myotonic muscular dystrophy-associated Cdc-42-binding kinase.
- BA6053 JH-X-119-01Summary: JH-X-119-01 is a potent and selective interleukin 1 receptor-related kinase 1 inhibitor.
- BA6066 LarotinibSummary: Larotinib is a potent, broad-spectrum, orally active tyrosine kinase inhibitor (TKI).
- BA8301 NPD10084Summary: NPD10084 is a pyruvate kinase inhibitor that inhibits non-glycolytic signaling in cancer cells.
- BA8302 EtavopivatSummary: Etavopivat is a potent, selective, orally active erythrocyte pyruvate kinase activator.
- BA8344 SGK1-IN-1Summary: SGK1-IN-1 is a highly active, selective inhibitor of serum- and glucocorticoid-regulated kinase 1.
- BA8784 IruplinalkibSummary: Iruplinalkib (WX-0593) is a potent, selective, orally active and tyrosine kinase inhibitor.
- BA8804 VodobatinibSummary: Vodobatinib (K0706) is a potent third-generation, and orally active, tyrosine kinase inhibitor.
- BA8806 VamotinibSummary: Vamotinib (PF-114) is a potent, selective tyrosine kinase inhibitor with oral activity.